TECHNIKER KRANKENKASSE has floated a tender for Contract notice: Pharmaceutical products. The project location is Germany and the tender is closing on 31 Aug 2019. The tender notice number is 282627-2017, while the TOT Ref Number is 15057749. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 31 Aug 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 15057749

Document Ref. No. : 282627-2017

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : TECHNIKER KRANKENKASSE
Office Name: Techniker Krankenkasse
Address: Bramfelder Str. 140
Town: Hamburg
Postal Code: 22305




Germany
Email :openhouse-rabattvertraege@tk.de
URL :www.tk.de/vergabe

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: The most economic tender
CPV code: 33600000, 33600000, 33600000
CPV Description: Pharmaceutical products.

"Open House Contracts 2017-08" Conclusion of non-exclusive rebate agreements pursuant to - 130a para. 8 SGB V with possible access to the market at any time.

The TK pursues discount agreements with all appropriate pharmaceutical entrepreneurs according to - 130a para SGB V concerning the active substances, active substance combinations and / or administration substances listed in section II.2, respectivelyThe non-exclusive discount agreements concluded in the open-house procedure of the TK are fundamentally used to override the period between the patent procedure of active substances, active substance combinations or dosage forms, effective potencies and the entry into force of exclusive discount contracts pursuant to - 130a para SGB V. The TK considers itself already, during the VerThe non-exclusive open-house discount agreements will be replaced by exclusive discount agreements concluded within the framework of an invitation to tender pursuant to the antitrust agreement. For the entry into force of the exclusive discount agreements TK will announce the open house discount agreements taking into account the relevant legal and contractual regulations. The experiencesIn the case of the TK, exclusive discount agreements are generally in force eight to ten months after the publication of the relevant notice in the Supplement to the Official Journal of the European Union. The future contracting parties are invited to regularly consult the Supplement to the Official Journal of the European Union in respect of these notices of invitation to tenderAccess to this open-house procedure is possible at any time within the term of the agreement. A contract is concluded with all pharmaceutical entrepreneurs who meet the requirements of Annex 4 to the contract (self-declaration for admission and the company) and confirm this by their signature.

The present notice does not concern the award of an oeffentliContract within the meaning of the German Law on Laws of Conduct (2014/24 / EC) and the antitrust law. In the interest of the broadest possible information to the interested pharmaceutical entrepreneurs, this notice will be published in the Supplement to the Official Journal of the European Union. The procedure "Open procedure" used in the context of the present notice text (point IV.1.1)) and the indication of the criteria for the award of the contract (point II.2.5)) are owed to the specifications of the announcement form and have no other meaning. With this, as well as with the use of the medium "TED", there is no submission to any legal regulations, the validity of which is not obligatoryDiscount agreements only with pharmaceutical entrepreneurs i. P. - 4 para. 18 AMG, whereby the property of the contractual partners as pharmaceutical entrepreneurs refers to the drugs offered in each case. It should be noted that medicinal products within the scope of the AMG may only be marketed by a pharmaceutical contractor, In another Member State of the European Union or in another Contracting State to the Agreement on the European Economic Area (Article 9 (2), first sentence, of the AMG). Local representatives of a pharmaceutical entrepreneur can only participate if they are themselves pharmaceutical entrepreneurs, P. - 4 para. 18 AMG with regard to the respectively appE-mails are only available in electronic form on the website http://www.tk.de/vergabe.

Questions concerning this procedure and / or the participation and contract documents are transferred to the TC A central contact person exclusively by e-mail to the address mentioned in section I.1) of the order notice-to transfer. In this case, the name "Open-house discount contracts 2017-08" should be indicated for allocation purposes in the subject.

Note to point I.3): The participation and contract documents shall be given to all pharmaceutical entrepreneurs as defined in Section II.2.4) and III.1.1) Note to section IV.2.7): Access to this open-house procedure is within the contract periodT possible at any time. All contract offers are opened and checked with the entrance. Please note that the notification for discount medicines in pharmacy software for the first calendar month can only be guaranteed if the written contract documents are complete and signed up to the third of the respective previous month of the TC. The DAtum of the entry at the TK (see participation and contract documents)
Internet address (URL): www.tk.de/vergabe
Directive: Classical Directive (2014/24/EU)

Documents

 Tender Notice